Tillmanns J, Hage S, Borst E, Wardin J, Eickhoff J, Klebl B
Cells. 2023; 12(8).
PMID: 37190072
PMC: 10137179.
DOI: 10.3390/cells12081162.
Forte E, Li M, Butun F, Hu Q, Borst E, Schipma M
Microbiol Spectr. 2023; 11(1):e0314422.
PMID: 36645269
PMC: 9927211.
DOI: 10.1128/spectrum.03144-22.
Borst E, Harmening S, Sanders S, Caragliano E, Wagner K, Lenac Rovis T
mBio. 2022; 13(5):e0100722.
PMID: 36066102
PMC: 9600257.
DOI: 10.1128/mbio.01007-22.
Krauter S, Buscher N, Brauchle E, Ortega Iannazzo S, Penner I, Kramer N
Vaccines (Basel). 2022; 10(8).
PMID: 36016214
PMC: 9413975.
DOI: 10.3390/vaccines10081326.
OBrien B, Mokry R, Schumacher M, Pulakanti K, Rao S, Terhune S
iScience. 2022; 25(4):104098.
PMID: 35391828
PMC: 8980761.
DOI: 10.1016/j.isci.2022.104098.
Molecular Tools for Targeted Control of Nerve Cell Electrical Activity. Part II.
Kolesov D, Sokolinskaya E, Lukyanov K, Bogdanov A
Acta Naturae. 2022; 13(4):17-32.
PMID: 35127143
PMC: 8807539.
DOI: 10.32607/actanaturae.11415.
Mouse Cytomegalovirus Encodes a Non-essential, Nuclear, - Expressed Protein Required for Efficient Viral Replication.
Eilbrecht M, Le-Trilling V, Trilling M
Front Cell Infect Microbiol. 2020; 10:171.
PMID: 32432049
PMC: 7214618.
DOI: 10.3389/fcimb.2020.00171.
Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function.
Adamson C, Nevels M
Viruses. 2020; 12(1).
PMID: 31963209
PMC: 7019229.
DOI: 10.3390/v12010110.
An Influenza Virus Hemagglutinin-Based Vaccine Platform Enables the Generation of Epitope Specific Human Cytomegalovirus Antibodies.
Behzadi M, Stein K, Bermudez-Gonzalez M, Simon V, Nachbagauer R, Tortorella D
Vaccines (Basel). 2019; 7(2).
PMID: 31207917
PMC: 6630953.
DOI: 10.3390/vaccines7020051.
Development of novel vaccines against human cytomegalovirus.
Cui X, Snapper C
Hum Vaccin Immunother. 2019; 15(11):2673-2683.
PMID: 31017831
PMC: 6930071.
DOI: 10.1080/21645515.2019.1593729.
Drug-Inducible Control of Lethality Genes: A Low Background Destabilizing Domain Architecture Applied to the Gal4-UAS System in Drosophila.
Kogenaru M, Isalan M
ACS Synth Biol. 2018; 7(6):1496-1506.
PMID: 29733646
PMC: 6008732.
DOI: 10.1021/acssynbio.7b00302.
Multiplex CRISPR/Cas9 system impairs HCMV replication by excising an essential viral gene.
Gergen J, Coulon F, Creneguy A, Elain-Duret N, Gutierrez A, Pinkenburg O
PLoS One. 2018; 13(2):e0192602.
PMID: 29447206
PMC: 5813945.
DOI: 10.1371/journal.pone.0192602.
Chemogenetic Tools for Causal Cellular and Neuronal Biology.
Atasoy D, Sternson S
Physiol Rev. 2018; 98(1):391-418.
PMID: 29351511
PMC: 5866359.
DOI: 10.1152/physrev.00009.2017.
miRNA-mediated targeting of human cytomegalovirus reveals biological host and viral targets of IE2.
Moller R, Schwarz T, Noriega V, Panis M, Sachs D, Tortorella D
Proc Natl Acad Sci U S A. 2018; 115(5):1069-1074.
PMID: 29339472
PMC: 5798380.
DOI: 10.1073/pnas.1719036115.
Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection.
Schleiss M, Permar S, Plotkin S
Clin Vaccine Immunol. 2017; 24(12).
PMID: 29046308
PMC: 5717185.
DOI: 10.1128/CVI.00268-17.
Mutual Interplay between the Human Cytomegalovirus Terminase Subunits pUL51, pUL56, and pUL89 Promotes Terminase Complex Formation.
Neuber S, Wagner K, Goldner T, Lischka P, Steinbrueck L, Messerle M
J Virol. 2017; 91(12).
PMID: 28356534
PMC: 5446633.
DOI: 10.1128/JVI.02384-16.
The Viral Bcl-2 Homologs of Kaposi's Sarcoma-Associated Herpesvirus and Rhesus Rhadinovirus Share an Essential Role for Viral Replication.
Gallo A, Lampe M, Gunther T, Brune W
J Virol. 2017; 91(6).
PMID: 28053098
PMC: 5331788.
DOI: 10.1128/JVI.01875-16.
Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand.
Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E
PLoS Pathog. 2016; 12(12):e1006015.
PMID: 27907183
PMC: 5131914.
DOI: 10.1371/journal.ppat.1006015.
Cytomegalovirus Vaccines: Current Status and Future Prospects.
Anderholm K, Bierle C, Schleiss M
Drugs. 2016; 76(17):1625-1645.
PMID: 27882457
PMC: 5628252.
DOI: 10.1007/s40265-016-0653-5.
Cytomegalovirus vaccines under clinical development.
Schleiss M
J Virus Erad. 2016; 2(4):198-207.
PMID: 27781101
PMC: 5075346.